PHARMORUBICIN Solution for injection or infusion Ref.[27631] Active ingredients: Epirubicin

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2021  Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

Product name and form

Pharmorubicin 2 mg/ml Solution for Injection or Infusion.

Pharmaceutical Form

Solution for injection or infusion.

Red, sterile, preservative-free, aqueous solution.

Qualitative and quantitative composition

Epirubicin hydrochloride 2 mg per ml

5 ml vials contain 10 mg of epirubicin hydrochloride

10 ml vials contain 20 mg of epirubicin hydrochloride

25 ml vials contain 50 mg of epirubicin hydrochloride

100 ml vials contain 200 mg epirubicin hydrochloride.

Excipient with known effect:

Pharmorubicin 10 mg/5 ml (2 mg/ml) solution for injection or infusion contains 17.7 mg of sodium in each 5 ml vial.

Pharmorubicin 20 mg/10 ml (2 mg/ml) solution for injection or infusion contains 35.4 mg of sodium in each 10 ml vial.

Pharmorubicin 50 mg/25 ml (2 mg/ml) solution for injection or infusion contains 88.5 mg of sodium in each 25 ml vial.

Pharmorubicin 200 mg/100 ml (2 mg/ml) solution for injection or infusion contains 354 mg of sodium in each 100 ml vial.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Epirubicin

Epirubicin is a cytotoxic active antibiotic from the anthracycline group. The mechanism of action of epirubicin is related to its ability to bind to DNA. Cell culture studies have shown rapid cell penetration, localisation in the nucleus and inhibition of nucleic acid synthesis and mitosis.

List of Excipients

Hydrochloric acid
Sodium chloride
Water for injections

Pack sizes and marketing

Colourless glass 5ml, 10ml, 25ml, or 100ml vial (type I), with Teflon-faced chlorobutyl rubber bung and aluminium cap with inset grey polypropylene disk.

Colourless polypropylene 5ml, 10ml, 25ml or 100ml vial with Teflon faced halobutyl-rubber stopper and aluminium cap with plastic flip-off top.

Marketing authorization holder

Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

Marketing authorization dates and numbers

PL 00057/1023

14th May 2004

Drugs

Drug Countries
PHARMORUBICIN Nigeria, New Zealand, Singapore, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.